F. Perros (Le Kremlin Bicetre, France), L. Price (London, United Kingdom), D. Montani (Le Kremlin-Bicêtre, France), H. Bogaard (Amsterdam, Netherlands)
Cigarette smoke- and hypoxia-induced imbalanced vasoactive gene expression in human pulmonary artery smooth muscle cells A. Alqarni (Nottingham, United Kingdom)
| |
Common bile duct and portal vein ligations increased right ventricular pressure in rat: a new experimental model F. Ketabchi (Shiraz, Islamic Republic of Iran)
| |
Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension D. Iloska (Bad Nauheim, Germany)
| |
The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43 M. Htet (Glasgow, United Kingdom)
| |
Investigating redox sensitive sex differences in serotonin-induced proliferation and migration in rat pulmonary artery smooth muscle cells. K. Hood (Glasgow, United Kingdom)
| |
Histone Deacetylase 7 regulates master transcription factors and modulates mitochondrial function E. Gamen (Bad Nauheim, Germany)
| |
A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension C. Udjus (Oslo, Norway)
| |
Nintedanib relaxes human pulmonary arteries more potently than murine C. Martin (Aachen, Germany)
| |
Dasatinib increases endothelial permeability leading to pleural effusion C. Phan (le kremlin bicetre dedex, France)
| |
Administration of mitomycin results in pulmonary hypertension and vascular remodeling in rabbits R. Quarck (Leuven, Belgium)
| |
Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinil. M. Corboz (Bridgewater, United States of America)
| |
The non-prostanoid IP receptor agonist, APD811 (ralinepag) has potent antiproliferative and vasorelaxant properties in human pulmonary artery L. Clapp (London, United Kingdom)
| |
The selective Rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates experimental pulmonary hypertension S. Cavalli (Parma, Italy)
| |
Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension A. McNair (Glasgow, United Kingdom)
| |
Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model. A. Rocher (Valladolid, Spain)
| |
Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema K. Howell (Dublin, Ireland)
| |
Longitudinal cardiac changes in a SUGEN/Hypoxic Rat Model of Pulmonary Hypertension determined by Cardiac MRI G. Jayasekera (GLASGOW, United Kingdom)
| |
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension V. Smolders (Barcelona, Spain)
| |
Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model J. Bordenave (Le Kremlin-Bicêtre Cedex, France)
| |